|
A. SHRIVASTAVA ET AL: "Cannabidiol Induces Programmed Cell Death in Breast Cancer Cells by Coordinating the Cross-talk between Apoptosis and Autophagy", MOLECULAR CANCER THERAPEUTICS, vol. 10, no. 7, 12 May 2011 (2011-05-12), US, pages 1161 - 1172, XP055418898, ISSN: 1535-7163, DOI: 10.1158/1535-7163.MCT-10-1100
*
|
|
ABRAMS: "Integrating cannabis into clinical cancer care", CURRENT ONCOLOGY, vol. 23, 2016, pages S8 - S14
|
|
ATTAL ET AL.: "Lenalidomide, Bortezomib, and Dexamethasone with Transplantation for Myeloma", N. ENGL. J. MED., vol. 376, 2017, pages 1311 - 20
|
|
AVIELLO ET AL.: "Chemopreventive effect of the non-psychotropic phytocannabinoid cannabidiol on experimental colon cancer", J. MOL. MED., 2012, pages 10
|
|
BARBARA ROMANO ET AL: "Inhibition of colon carcinogenesis by a standardized Cannabis sativa extract with high content of cannabidiol", PHYTOMEDICINE, vol. 21, no. 5, 1 April 2014 (2014-04-01), AMSTERDAM, NL, pages 631 - 639, XP055605852, ISSN: 0944-7113, DOI: 10.1016/j.phymed.2013.11.006
*
|
|
BERGAMASCHI ET AL.: "Safety and Side Effects of Cannabidiol, a Cannabis sativa Constituent", CURRENT DRUG SAFETY, vol. 6, 2011, pages 13
|
|
BHATTACHARYYA ET AL.: "Opposite Effects of A-9-Tetraydrocannabinol and Cannbidiol on Human Brain Function and Psychopathology", NEUROPSYCHOPHARMACOLORY, vol. 35, 2010, pages 764 - 74
|
|
BLAZQUEZ ET AL.: "Cannabinoids Inhibit the Vascular Endothelial Growth Factor Pathway in Gliomas", CANCER RES., vol. 64, 2004, pages 5617 - 23
|
|
BOLOGNINI ET AL.: "Cannabidiolic acid prevents vomiting in Suncus murinus and nausea-induced behavior in rats by enhancing 5-HT1A receptor activation", BR. J. PHARMACOL., vol. 168, 2013, pages 1456 - 70
|
|
CAMPOS ET AL.: "Multiple mechanisms involved in the large-spectrum therapeutic potential of cannabidiol in psychiatric disorders", PHIL. TRANS. R. SOC. B, vol. 367, 2012, pages 3364 - 78
|
|
CARCHMAN ET AL.: "The inhibition of DNA synthesis by cannabinoids", CANCER RES., vol. 36, 1976, pages 95 - 100, XP000979754
|
|
CARLINICUNHA: "Hypnotic and Antiepileptic Effects of Cannabidiol", J. CLIN. PHARMACOL., vol. 21, 1981, pages 417S - 427S
|
|
CHAKRAVARTI ET AL.: "Cannabinoids as therapeutic agents in cancer: current status and future impliciations", ONCOTARGET, vol. 5, 2014, pages 5852 - 72, XP055460846, DOI: doi:10.18632/oncotarget.2233
|
|
CONROY ET AL.: "FOLFIRINOX versus Gemcitabine for Metastatic pancreatic Cancer", NEW ENGL. J. MED., vol. 364, 2011, pages 1817 - 25, XP002730536, DOI: doi:10.1056/NEJMoa1011923
|
|
CRIPPA ET AL.: "Effects of Cannabidiol (CBD) on Regional Cerebral Blood Flow", NEUROPSYCHOPHARMACOLOGY, vol. 29, 2004, pages 417 - 26
|
|
CRIPPA ET AL.: "Neural basis of anxiolytic effects of cannabidiol (CBD) in generalized social anxiety disorder: a preliminary report", J. PSYCHOPHARMACOL., vol. 25, 2011, pages 121 - 30
|
|
CUNHA ET AL.: "Chronic Administration of Cannabidiol to Healthy Volunteers and Epileptic Patients", PHARMACOL., vol. 21, 1980, pages 175 - 85, XP009139434, DOI: doi:10.1159/000137430
|
|
D'ARGENIO ET AL.: "Up-regulation of anandamide levels as an endogenous mechanism and a pharmacological strategy to limit colon inflammation", FASEB J. EXPRESS ARTICLE, 2006, pages 16
|
|
DE PETROCELLIS ET AL.: "Plant-derived cannabinoids modulate the activity of transient receptor potential channels of ankyrin type-1 and melastatin type-8", J. PHARMACOL. EXP. THER., vol. 325, 2008, pages 1007 - 15
|
|
DEL PULGAR ET AL.: "Cannabinoids Protect Astrocytes from Ceramide-induced Apoptosis through the Phosphatidylinositol 3-Kinase/Protein Kinase B Pathway", J. BIOL. CHEM., vol. 277, 2002, pages 36527 - 33
|
|
DEL PULGAR ET AL.: "De novo-synthesized ceramide is involved in cannabinoid-induced apoptosis", BIOCHEM. J., vol. 363, 2002, pages 183 - 88
|
|
DEVINSKY ET AL.: "Trial of Cannabidiol for Drug-Resistant Seizures in the Dravet Syndrome", NEW ENGL. J. MED., vol. 376, 2017, pages 2011 - 20, XP055581640, DOI: doi:10.1056/NEJMoa1611618
|
|
DOLORES HERNÁN PÉREZ DE LA OSSA ET AL: "Local Delivery of Cannabinoid-Loaded Microparticles Inhibits Tumor Growth in a Murine Xenograft Model of Glioblastoma Multiforme", PLOS ONE, vol. 8, no. 1, 22 January 2013 (2013-01-22), pages e54795, XP055512054, DOI: 10.1371/journal.pone.0054795
*
|
|
EISENHAUER ET AL.: "New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1", EUR. J. CANCER, vol. 45, 2009, pages 228 - 47, XP025841550, DOI: doi:10.1016/j.ejca.2008.10.026
|
|
ELBAZ MOHAMAD ET AL: "Modulation of the tumor microenvironment and inhibition of EGF/EGFR pathway: Novel anti-tumor mechanisms of Cannabidiol in breast cancer", MOLECULAR ONCOLOGY, vol. 9, no. 4, 1 April 2015 (2015-04-01), pages 906 - 919, XP029125030, ISSN: 1574-7891, DOI: 10.1016/J.MOLONC.2014.12.010
*
|
|
ENGELS ET AL.: "Medicinal Cannabis Does Not Influence the Clinical Pharmacokinetics of Irinotecan and Docetaxel", THE ONCOLOGIST, vol. 12, 2007, pages 291 - 300
|
|
FOWLER: "Delta(9)-tetrahydrocannabinol and cannabidiol as potential curative agents for cancer: A critical examination of the preclinical literature", CLIN. PHARMACOL. THER., vol. 97, 2015, pages 587 - 96
|
|
FRIEDMAN: "In vivo effects of cannabinoids on macromolecular biosynthesis in Lewis lung carcinomas", CANCER BIOCHEM. BIOPHYS., vol. 2, 1977, pages 51 - 54
|
|
FUGH-BERMAN ET AL.: "Medical Cannabis, Adverse Effects & Drug Interactions", GOVERNMENT OF THE DISTRICT OF COLUMBIA DEPARTMENT OF HEALTH SLIDE PRESENTATION, pages 38
|
|
FUSAR-POLI ET AL.: "Distinct Effects of A9-Tetrahydrocannabinol and Cannabidiol on Neural Activation During Emotional Processing", ARCH. GEN. PSYCHIATRY, vol. 66, 2009, pages 95 - 105
|
|
GABRIELLA AVIELLO ET AL: "Chemopreventive effect of the non-psychotropic phytocannabinoid cannabidiol on experimental colon cancer", JOURNAL OF MOLECULAR MEDICINE, SPRINGER, BERLIN, DE, vol. 90, no. 8, 10 January 2012 (2012-01-10), pages 925 - 934, XP035084662, ISSN: 1432-1440, DOI: 10.1007/S00109-011-0856-X
*
|
|
GALVE-ROPERH ET AL.: "Anti-tumoral action of cannbinoids: Involvement of sustained ceramide accumulation and extracellular signal-regulated kinase activation", NATURE MED., vol. 6, 2000, pages 313 - 19
|
|
GEFFRETY ET AL.: "Drug-drug interaction between clobazam and cannabidiol in children with refractory epilepsy", EPILEPSIA, vol. 56, 2015, pages 1246 - 51, XP002790755, DOI: doi:10.1111/epi.13060
|
|
GREEN ET AL.: "A decreased influence of cannabinoids on macromolecular biosynthesis and cell proliferation in human cells which metabolize polycyclic hydrocarbon carcinogens", ANTICANCER RES., vol. 3, 1983, pages 211 - 17
|
|
GUZMAN ET AL.: "A pilot clinical study of A9-tetrahydrocannbinol in patients with recurrent glioblastoma multiforme", BR. J. CANCER, vol. 95, 2006, pages 197 - 203, XP055512051, DOI: doi:10.1038/sj.bjc.6603236
|
|
HALLAK ET AL.: "Performance of schizophrenic patients in the Stroop Color Word Test and electrodermal responsiveness after acute administration of cannabidiol (CBD", REVISTA BRASILEIRA DE PSIQUIATRIA, vol. 32, 2010, pages 6
|
|
HARVEYMECHOULAM: "Metabolites of cannabidiol identified in human urine", XENOBIOTICA, vol. 20, 1990, pages 303 - 20
|
|
HOLLAND ET AL.: "The effects of cannabinoids on P-glycoprotein transport and expression in multidrug resistant cells", BIOCHEM. PHARMACOL., vol. 71, 2006, pages 1146 - 54, XP025043237, DOI: doi:10.1016/j.bcp.2005.12.033
|
|
HORNBYPROUTY: "Involvement of cannbinoids receptors in gut motility and visceral perception", BR. J. PHARMACOL., vol. 141, 2004, pages 1335 - 45
|
|
HOTTINGER ET AL.: "Tumor treating fields: a novel treatment modality and its use in brain tumors", NEURO-ONCOL., vol. 18, 2016, pages 1338 - 49
|
|
HOWLET ET AL.: "Regulation of adenylate cyclase by cannabinoid drugs. Insights based on thermodynamic studies", BIOCHEM. PHARMACOL., vol. 38, 1989, pages 3297 - 304, XP023832925, DOI: doi:10.1016/0006-2952(89)90628-X
|
|
HOWLETTFLEMING: "Cannabinoid inhibition of adenylate cyclase. Pharmacology of the response in neuroblastoma cell membranes", MOL. PHARMACOL., vol. 26, 1984, pages 532 - 38
|
|
HUESTIS: "Human Cannabinoid Pharmacokinetics", CHEM. BIODIVERS., vol. 4, 2007, pages 1770 - 804
|
|
HYUNG CHOI ET AL: "Cannabidiol Induces Cytotoxicity and Cell Death via Apoptotic Pathway in Cancer Cell Lines", BIOMOLECULES & THERAPEUTICS, 1 January 2008 (2008-01-01), pages 87 - 94, XP055521538, Retrieved from the Internet <URL:http://www.biomolther.org/journal/view.html?uid=25&vmd=Full>
*
|
|
IANNOTTI ET AL.: "Nonpsychotropic plant cannabinoids, cannabidivarin (CBDV) and cannabidiol (CBD), activate and desensitize transient receptor potential vanilloid 1 (TRPV1) channels in vitro: potential for the treatment of neuronal hyperexcitability", ACS CHEMICAL NEUROSCIENCE, vol. 5, 2014, pages 1131 - 41
|
|
IFFLANDGROTENHERMEN: "An Update on Safety and Side Effects of Cannabidiol: a Review of Clinical Data and Relevant Animal Studies", CANNABIS AND CANNABINOID RESEARCH, vol. 2.1, 2017, pages 16
|
|
IVANOV ET AL.: "Regulation of human glioblastoma cell death by combined treatment of cannabidiol, Y-radiation and small molecule inhibitors of cell signaling pathways", ONCOTARGET, vol. 8, 2017, pages 74068 - 95
|
|
IZZO ET AL.: "Non-psychotropic plant cannabinoids: new therapeutic opportunities from an ancient herb", TRENDS PHARMACOL. SCI., vol. 30, 2009, pages 515 - 27, XP026639899, DOI: doi:10.1016/j.tips.2009.07.006
|
|
IZZOCAMILLERI: "Cannabinoids in intestinal inflammation and cancer", PHARMACOL. RES., vol. 60, 2009, pages 117 - 25
|
|
JACOBSSON ET AL.: "Serum-dependent effects of tamoxifen and cannabinoids upon C6 glioma cell viability", BIOCHEM. PHARMACOL., vol. 60, 2000, pages 1807 - 13, XP009121672, DOI: doi:10.1016/S0006-2952(00)00492-5
|
|
JACOBSSON STIG O P ET AL: "Serum-dependent effects of tamoxifen and cannabinoids upon C6 glioma cell viability", BIOCHEMICAL PHARMACO, ELSEVIER, US, vol. 60, no. 12, 15 December 2000 (2000-12-15), pages 1807 - 1813, XP009121672, ISSN: 0006-2952, [retrieved on 20001130], DOI: 10.1016/S0006-2952(00)00492-5
*
|
|
KIMBALL ET AL.: "Agonists of cannabinoid receptor 1 and 2 inhibit experimental colitis induced by oil of mustard and by dextran sulfate sodium", AM. J. PHYSIOL. GASTROINTEST. LIVER PHYSIOL., vol. 291, 2006, pages G364 - G371
|
|
KOGAN ET AL.: "A Cannabinoid Quinone Inhibits Angiogenesis by Targeting Vascular Endothelial Cells", MOL. PHARMACOL., vol. 70, 2006, pages 51 - 59
|
|
KUMAR ET AL.: "International Myeloma Working Group consensus criteria for response and minimal residual disease assessment in multiple myeloma", LANCET ONCOL., vol. 17, 2016, pages e328 - 46, XP029663519, DOI: doi:10.1016/S1470-2045(16)30206-6
|
|
LADIN ET AL.: "Preclinical and Clinical Assessment of Cannabinoids as Anti-Cancer Agents", FRONTIERS IN PHARMACOLOGY, vol. 7, no. 361, 2016, pages 18, XP055478492, DOI: doi:10.3389/fphar.2016.00361
|
|
LEE: "CBD: How It Works", O'SHAUGHNESSEY'S, 2011, pages 14
|
|
LEWEKE ET AL.: "Cannabidiol enhances anandamide signaling and alleviates psychotic symptoms of schizophrenia", TRANSL. PSYCHIATRY, vol. 2, 2012, pages e94,7
|
|
LIGRESTI A ET AL: "Antitumor activity of plant cannabinoids with emphasis on the effect of cannabidiol on human breast carcinoma", JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, AMERICAN SOCIETY FOR PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, US, vol. 318, no. 3, 1 January 2006 (2006-01-01), pages 1375 - 1387, XP002540820, ISSN: 0022-3565, DOI: 10.1124/JPET.106.105247
*
|
|
LIGRESTI ET AL.: "Antitumor Activity of Plant Cannabinoids with Emphasis on the Effect of Cannabidiol on Human Breast Carcinoma", J. PHARMACOL. EXPERIMENTAL THERAPEUTICS, vol. 318, 2006, pages 1375 - 87, XP002540820, DOI: doi:10.1124/jpet.106.105247
|
|
LUCIANO DE PETROCELLIS ET AL: "Non-THC cannabinoids inhibit prostate carcinoma growth in vitro and in vivo : pro-apoptotic effects and underlying mechanisms", BRITISH JOURNAL OF PHARMACOLOGY, vol. 168, no. 1, 18 December 2012 (2012-12-18), UK, pages 79 - 102, XP055335428, ISSN: 0007-1188, DOI: 10.1111/j.1476-5381.2012.02027.x
*
|
|
MADRAS, UPDATE OF CANNABIS AND ITS MEDICAL USE, Retrieved from the Internet <URL:http://www.who.int/medicines/access/controlled-substances/6_2_cannabis_update.pdf>
|
|
MANJU SHARMA ET AL: "<i>In Vitro</i> Anticancer Activity of Plant-Derived Cannabidiol on Prostate Cancer Cell Lines", PHARMACOLOGY & PHARMACY, vol. 05, no. 08, 1 January 2014 (2014-01-01), United States, pages 806 - 820, XP055606160, ISSN: 2157-9423, DOI: 10.4236/pp.2014.58091
*
|
|
MARIA BEATRICE MORELLI ET AL: "The effects of cannabidiol and its synergism with bortezomib in multiple myeloma cell lines. A role for transient receptor potential vanilloid type-2", INTERNATIONAL JOURNAL OF CANCER, vol. 134, no. 11, 2 December 2013 (2013-12-02), US, pages 2534 - 2546, XP055304213, ISSN: 0020-7136, DOI: 10.1002/ijc.28591
*
|
|
MASSA ET AL.: "The endogenous cannabinoid system protects against colonic inflammation", J. CLIN. INVEST., vol. 113, 2004, pages 1202 - 09
|
|
MASSI ET AL.: "Cannabidiol as potential anticancer drug", BR. J. CLIN. PHARMACOL., vol. 75, 2012, pages 303 - 12
|
|
MASSI P ET AL: "The non-psychoactive cannabidiol triggers caspase activation and oxidative stress in human glioma cells", CELLULAR AND MOLECULAR LIFE SCIENCES, BIRKHÄUSER-VERLAG, BA, vol. 63, no. 17, 10 August 2006 (2006-08-10), pages 2057 - 2066, XP019419223, ISSN: 1420-9071, DOI: 10.1007/S00018-006-6156-X
*
|
|
MCALLISTER ET AL.: "The antitumor activity of plant-derived non-psychoactive cannabinoids", J. NEUROIMMUNE PHARMACOL., vol. 10, 2015, pages 255 - 67
|
|
MCHUGH ET AL.: "Inhibition of Human Neutrophil Chemotaxis by Endogenous Cannabinoids and Phytocannabinoids: Evidence for a Site Distinct from CB 1 and CB2", MOL. PHARMACOL., vol. 73, 2008, pages 441 - 50
|
|
MCVEY ET AL.: "Endocannabinoids Induce Ileitis in Rats via the Capsaicin Receptor (VR1", J. PHARMACOL. EXPERIMENTAL THERAPEUTICS, vol. 304, 2003, pages 713 - 22
|
|
MECHOULAM ET AL.: "Cannabidiol—recent advances", CHEM. BIODIVERS., vol. 4, 2007, pages 1678 - 92, XP009115726, DOI: doi:10.1002/cbdv.20079014
|
|
MEHRZAD ET AL.: "Bevacizumab plus FOLFOX or FOLFIRI regimens on patients with unresectable liver-only metastases of metastatic colorectal cancer", ADV. BIOMED. RES., vol. 5, 2016, pages 11
|
|
MOLNAR ET AL.: "Membrane associated antitumor effects of crocine-, ginsenoside- and cannabinoid derivates", ANTICANCER RES., vol. 20, 2000, pages 861 - 67, XP009010607
|
|
MORELLI ET AL.: "The effects of cannabidiol and its synergism with bortezomib in multiple myeloma cell lines. A role for transient receptor potential vanilloid type-2", INT. J. CANCER, vol. 134, 2014, pages 2534 - 46, XP055304213, DOI: doi:10.1002/ijc.28591
|
|
MUNSON ET AL.: "Antineoplastic activity of cannabinoids", J. NATL. CANCER INST., vol. 55, 1975, pages 597 - 602
|
|
MURISON ET AL.: "Cannabinoids induce incomplete maturation of cultured human leukemia cells", PROC. NAT'L. ACAD. SCI. (USA, vol. 84, 1987, pages 5414 - 18, XP002336120, DOI: doi:10.1073/pnas.84.15.5414
|
|
NABISSI ET AL.: "Triggering of the TRPV2 channel by cannabidiol sensitizes glioblastoma cells to cytotoxic chemotherapeutic agents", CARCINOGENESIS, vol. 34, 2013, pages 48 - 57
|
|
NASSER ET AL.: "Crosstalk between Chemokine Receptor CXCR4 and Cannabinoid Receptor CB2 in Modulating Breast Cancer Growth and Invasion", PLOS ONE, vol. 6, 2011, pages e23901,9
|
|
ROCK ET AL.: "Evaluation of the potential of the phytocannabinoids, cannabidivarin (CBDV) and A9-tetrahydrocannabivarin (THCV), to produce CB 1 receptor inverse agonism symptoms of nausea in rats", BR. J. PHARMACOL., vol. 170, 2013, pages 671 - 78, XP055125112, DOI: doi:10.1111/bph.12322
|
|
RUH ET AL.: "Failure of cannabinoid compounds to stimulate estrogen receptors", BIOCHEM. PHARMACOL., vol. 53, 1997, pages 35 - 41
|
|
SANCHEZ ET AL.: "Inhibition of Glioma Growth in Vivo by Selective Activation of the CB2 Cannabinoid Receptor", CANCER RES., vol. 61, 2001, pages 5784 - 89
|
|
SCOTT K A ET AL: "Enhancing the activity of cannabidiol and other cannabinoids in vitro through modifications to drug combinations and treatment schedules", ANTICANCER RESEARCH - INTERNATIONAL JOURNAL OF CANCER RESEARCH AND TREATMENT, INTERNATIONAL INSTITUTE OF ANTICANCER RESEARCH, GR, vol. 33, no. 10, 30 September 2013 (2013-09-30), pages 4373 - 4380, XP009504618, ISSN: 0250-7005
*
|
|
SHANNONOPILA-LEHMAN: "Effectiveness of Cannabidiol Oil for Pediatric Anxiety and Insomnia as Part of Posttraumatic Stress Disorder: A Case Report", PERM. J., vol. 20, no. 16-005, 2016, pages 4
|
|
SHRISTAVA ET AL.: "Cannabidiol Induces Programmed Cell Death in Breast Cancer Cells by Coordinating the Cross-talk between Apoptosis and Autophagy", MOL. CANCER THERAP., vol. 10, 2011, pages 1161 - 72, XP055418898, DOI: doi:10.1158/1535-7163.MCT-10-1100
|
|
SINDISWAT LUKHELE ET AL: "Cannabidiol rather than extracts inhibit cell growth and induce apoptosis in cervical cancer cells", BMC COMPLEMENTARY AND ALTERNATIVE MEDICINE, BIOMED CENTRAL LTD, LONDON, UK, vol. 16, no. 1, 1 September 2016 (2016-09-01), pages 1 - 16, XP021267925, DOI: 10.1186/S12906-016-1280-0
*
|
|
STONE: "Glutamatergic antipsychotic drugs: a new dawn in the treatment of schizophrenia?", THER. ADV. PSYCHOPHARMACOL., vol. 1, 2011, pages 5 - 18
|
|
SZEPSENWOL ET AL.: "Experimentally produced synovial sarcoma in mice", ONCOL., vol. 42, 1985, pages 61 - 67
|
|
TAKEDA ET AL.: "Down-regulation of cyclooxygenase-2 (COX-2) by cannabidiolic acid in human breast cancer cells", J. TOXICOLOGICAL SCIENCES, vol. 39, 2014, pages 711 - 16
|
|
THOMASCOLEY: "Overcoming Multidrug Resistance in Cancer: An Update on the Clinical Strategy of Inhibiting P-Glycoprotein", CANCER CONTROL, vol. 10, 2003, pages 159 - 65
|
|
TORRES ET AL.: "A Combined Preclinical Therapy of Cannabinoids and Temozolomide against Glioma", MOL CANCER THERAPEUTICS, vol. 10, 2011, pages 90 - 103, XP009150445, DOI: doi:10.1158/1535-7163.MCT-10-0688
|
|
TORRES SOFIA ET AL: "A Combined Preclinical Therapy of Cannabinoids and Temozolomide against Glioma", MOLECULAR CANCER THERAPEUTICS, AMERICAN ASSOCIATION FOR CANCER RESEARCH, US, vol. 10, no. 1, 1 January 2011 (2011-01-01), pages 90 - 103, XP009150445, ISSN: 1535-7163, DOI: 10.1158/1535-7163.MCT-10-0688
*
|
|
UJVARYHANUS: "Human Metabolites of Cannabidiol: A Review on Their Formation, Biological Activity, and Relevance in Therapy", CANNABIS AND CANNABINOID RESEARCH, vol. 1.1, 2016, pages 90 - 101
|
|
UNO ET AL.: "a-Bisabolol Inhibits Invasiveness and Motility in Pancreatic Cancer Through KISS1R Activation", ANTICANCER RES., vol. 36, 2016, pages 583 - 90
|
|
VACCANI ET AL.: "Cannabidiol inhibits human glioma cell migration through a cannabinoid receptor-independent mechanism", BR. J. PHARMACOL., vol. 144, 2005, pages 1032 - 36, XP002540821, DOI: doi:10.1038/sj.bjp.0706134
|
|
VELASCO ET AL.: "Anticancer mechanisms of cannabinoids", CURR. ONCOL., vol. 23, 2016, pages S23 - S32
|
|
ZHORNITSKYPOTVIN: "Cannabidiol in Humans—The Quest for Therapeutic Targets", PHARMACEUTICALS, vol. 5, 2012, pages 529 - 52
|
|
ZHU ET AL.: "Characterization of P-glycoprotein Inhibition by Major Cannabinoids from marijuana", J. PHARMACOL. EXPERIMENTAL THERAPEUTICS, vol. 317, 2006, pages 850 - 57
|
|
ZUARDI ET AL.: "A Critical Review of the Antipsychotic Effects of Cannbidiol: 30 Years of a Translational Investigation", CURR. PHARMACEUTICAL DESIGN, vol. 18, 2012, pages 5131 - 40
|
|
ZUARDI: "Cannabidiol: from an inactive cannabinoid to a drug with wide spectrum of action", REV. BRAS. PSIQUIATR., vol. 30, 2008, pages 271 - 80, XP055267158, DOI: doi:10.1590/S1516-44462008000300015
|